Clinical Trial

ProofPilot to Host ‘Pharma Feud’ at the 16th Annual SCOPE Summit

NEW YORK, Jan. 30, 2025 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that enhances engagement for sponsors, sites,…

11 months ago

Medicare Advantage Members Gain Access to Innovative Digital Therapeutics Through New Partnership

Kaia Health and eternalHealth Partner to Deliver Affordable, Effective Care to Seniors in Massachusetts and Arizona NEW YORK, Jan. 30, 2025…

11 months ago

Red Light Holland, in Partnership with FDA-Compliant and DEA-Registered Irvine Labs, Updates R&D Plan Focused On Commercialization

Toronto, Ontario--(Newsfile Corp. - January 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

11 months ago

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control

European patents expand coverage for both essential components of FemBloc for fallopian tube occlusion, resulting in non-surgical permanent contraceptionATLANTA, Jan.…

11 months ago

Evaxion announces pricing of $10.8 million public offering

COPENHAGEN, Denmark, January 30, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™…

11 months ago

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Boston (January 30, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to…

11 months ago

Adhere+ Launches Industry-First Spanish-Language Integration for Remote Therapeutic Monitoring

New Foreign Language Capability Enhances Healthcare Equity and Accessibility, Empowering Practices to Support Diverse Patient Populations WASHINGTON, Jan. 29, 2025 /PRNewswire/…

11 months ago

NervGen Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Vancouver, Canada--(Newsfile Corp. - January 29, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated…

11 months ago

Hemostemix Announces First Sales Orders for ACP-01

Calgary, Alberta--(Newsfile Corp. - January 29, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

11 months ago

Image Analysis Group Announces Release of DYNAMIKA V.7, their Award-Winning Cloud Platform for Clinical Trial Imaging

DYNAMIKA V.7 has achieved the British Standards Institute (BSI) surveillance audit certification following a recent SOC II Type I compliance…

11 months ago